Friday, February 28, 2025 | 03:33 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

USFDA okays emergency use of Gilead drug for hospitalised Covid-19 patients

Gilead CEO Daniel O'Day has announced that the company is donating 1.5 million vials of the medicine

Health workers collect swab samples from people for COVID -19 tests,in New Delhi. Photo: PTI
Premium

US President Donald Trump called Remdesivir use

Press Trust of India
The US food and drug regulatory body has allowed emergency use of an investigational anti-viral vaccine to treat COVID-19 patients after some researches, including one led by an Indian-American physician, found that the drug helped recover some of the infected cases faster.

The Food and Drug Administration (FDA) gave emergency use authorisation (EUA) for the use of investigational anti-viral Remdesivir in the treatment of COVID-19 patients.

The FDA authorisation came after researches, including one led by Indian-American physician Aruna Subramanian, reported Remdesivir shortened the recovery times in people who have fallen ill from the new coronavirus.

I'm pleased to announce that Gilead now

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in